Shares of Novartis NVS Amgen AMGN and Ionis Pharmaceuticals IONS  are  lower this morning after Novartis' cholesterol drug pelacarsen failed to reduce heart risks despite lowering harmful cholesterol Lp(a) as reported Friday after the close. 08-SEP-2026 05:38 AM ET